Key features and details | |
Cat. No. | MABL-779 |
Name | Anti-CD20 mAbs |
Clone No. | AFD- 1F5 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | depleting, stimulatory, therapeutic |
Species Reactivity | Human |
Basic Information | |
Specificity | This antibody is specific for CD20, which is expressed by normal and malignant B cells. |
Alternative Name | MS4A1; B-lymphocyte antigen CD20; B-lymphocyte surface antigen B1; Bp35; Leukocyte surface antigen Leu-16; Membrane-spanning 4-domains subfamily A member 1; E9PPL6; P19437 |
UniProt | P11836 |
Immunogen | This antibody was raised by hyperimmunising BALB/c mice with the Raji Burkett's lymphoma line and the NALM-6 pre B leukaemia line. |
Application Notes | This antibody, either alone or in combination with T cell derived factors, induces B cell proliferation via CD20 cross-linking (Clark et al, 1985).When administered to patients with refractory malignant B cell lymphomas, this antibody depletes circulating and lymph node tumour cells, with minimal toxicity (Press et al, 1987). A murine/human chimeric IgG1 construct of this antibody has been shown to lyse Burkitt's lymphoma (5RAJI) cells (Stockmeyer et al, 2000), while IgG1 and IgA2 isotypes of this antibody have been shown to kill B cells in vitro and in deplete B cells in vivo (Lohse et al, 2018). The humanized version of this antibody can be provided upon request. |
Antibody First Published | Ledbetter et al. Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets Human Immunology, 1986, Vol.15(1), pp.30-43 PMID:2419284 |
Note on publication | Describes the original generation of this antibody. |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |